Cel-Sci Corp (AMEX:CVM) (was HIV) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV)

CVM 6.630

-1.0%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SKARLOEY who wrote (2201)	11/10/1998 6:52:00 PM
From: Tom Shutters	Read Replies (1) of 2836

"Outpatient IL-2 therapy improves CD4 cell count and immune repertoire" ..."Dr. Carr's group therefore suggests that "IL-2 therapy may serve best...to preserve the immune repertoire rather than to restore lost immunity."... ama-assn.org Vaccine coctails begin to gain popularity. It is my opinion that HGP-30 will end up being used in a coctail like the one mentioned in this article. theaustralian.com.au Tom

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next